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Purpose: Maternal micronutrient deficiencies occurring during periconceptional, pregnancy, and 
postpartum periods are a leading cause of adverse pregnancy outcomes globally. The Dietary 
Reference Intakes (DRIs) are a set of reference values used to assess and guide nutrient intakes of 
healthy individuals. However, the current DRIs for pregnancy and lactation may be limited in their 
methods and included populations. The present study analyzed the current DRIs for their inclusion of 
pregnant women and geographic representativeness. Methods: Meta-research methods were 
applied to the DRI report for vitamins B6, B12, folate, and choline in four steps: search, screening, 
full-text data extraction, and data analysis. For each target micronutrient, sections that contributed 
data to setting the average requirement were focused on, “Selection of Indicators for Estimating the 
Requirement,” “Findings by Life Stage and Gender Group,” and “Tolerable Upper Intake Limit” for 
adults, pregnancy, and lactation sub-sections. Screening involved reviewing the reference list to 
determine whether a reference directly contributed to setting the DRI. Full-text data extraction of 
primary data was conducted in areas of: 1) administrative information; 2) study methods; 3) human 
population characteristics; and 4) non-human subjects. Descriptive analyses were performed to 
describe the inclusion of women, pregnant women, geographic patterns, and demographic diversity. 
Results: For Vitamin B12, 100% of indicator studies and 71% of life stages studies included women, 
with a total of 3,246 women participants. However, none of the indicator studies and 15% of life 
stages studies included pregnant women, with a total of 556 pregnant women participants. None of 
the indicator studies and 8% of life stages studies reported health measurements specific to women, 
pregnancy, or lactation. Geographically, 54% of studies were conducted in the United States, and 
18% took place in low-and middle-income countries. Data analysis is ongoing for the remaining 
micronutrients. Conclusions: Preliminary findings indicate that the body of evidence informing the 
current DRIs are limited in their inclusion of women and pregnant women. Numerous adverse 
pregnancy and birth outcomes are preventable through optimal maternal nutrition. Therefore, it is 
critical to ensure that the DRIs are suitable for their intended population. Despite their original intent 
for use in North America, the DRIs are widely adopted globally. Thus, geographic representation of 
the studies underlying the DRIs have implications for generalizability. 
ABSTRACT
BACKGROUND
• Meta-research methods were applied to the DRI report for Vitamin 
B6, Vitamin B12, Folate, and Choline in four steps: search, screening, 
full-text data extraction, and data analysis.
1. Search
• All studies which potentially contributed to the 1998 DRI report for 
B6, B12, folate, and Choline were searched.
2. Screening
• A panel of five experts reviewed the reference list to determine 
whether a reference directly contributed to setting the DRI for that 
micronutrient. 
• 224 human or animal primary studies, and 206 only human primary 
studies which were considered as contributing to the DRIs were 
ultimately included for Vitamins B12, B6, Folate, and Choline.
METHODS
Figure D: Percent of Studies Reporting Health Outcomes Specific 
to Women/ Pregnancy/ Lactation: B12, Folate, Choline and B6
RESULTS DISCUSSION & CONCLUSION
• Women and pregnant people are historically underrepresented in 
medical research. Over 90% of clinically approved drugs still lack 
information on safety, efficacy, and pharmacokinetics in pregnancy.1
• The Dietary Reference Intakes (DRIs), developed at the Institute of 
Medicine, are a general term for a set of reference values used to 
assess and guide nutrient intakes of healthy individuals.2
• DRIs are used to guide global nutrition policy, diet assessments, and 
pregnancy vitamin and mineral supplement recommendation levels.
• Maternal micronutrient deficiencies occurring during 
periconceptional, pregnancy, and postpartum periods are a leading 
cause of adverse pregnancy outcomes globally.3
• One-carbon metabolism micronutrients, including folate, choline, 
vitamin B6, and B12, are essential during pregnancy; deficiencies in 
these nutrients are associated with adverse outcomes including 
maternal preeclampsia and neural tube defects in the offspring.4
• We aimed at systematically investigating the body of evidence that 
informed the DRI values in terms of:
• The inclusion of pregnant people and women of 
reproductive age, and
• The geographic representation of these studies
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3. Data Abstraction
• Full-text data extraction of primary data from each study was performed 
in areas: 1) administrative information and study identification; 2) study 
methods; 3) human population characteristics; and 4) non-human 
subjects.
4. Data Analysis
• Descriptive analyses were performed to describe the inclusion of women, 
pregnant women, women of reproductive age, geographic patterns, and 
whether health outcomes specific to women/pregnancy/lactation were 
included. 
• For all characteristics analyzed, we focused on collecting data for the 
number and proportion of studies. Total sample size of women was also 
calculated. 
1. Similar to their historical exclusion in medical research, we found that pregnant and lactating people have been 
excluded from clinical nutrition research that informs the DRIs for Vitamins B6, B12, Folate, and Choline, despite the 
importance of these micronutrients during and after pregnancy for optimal health. (Figure C) 
2. The percent of studies reporting health outcomes specific to women/pregnancy/lactation, such as milk volume or 
low birth weight, varied significantly between the micronutrients analyzed. (Figure D)
• No studies informing the selection of indicators or for establishing the upper level (UL) reported specific health 
outcomes for B12 or Choline, which is problematic as optimal biomarkers  of micronutrient status may vary by 
reproductive state. 
3. The nutrient reference values were originally intended for use in North America, however, the DRIs are widely 
adopted and used globally, and so global reference values require underlying high-quality data representative of the 
global population, rather than primarily the US, the UK, and high-income countries, which was the case for one-the 
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Figure C: Characterization of Included Study Population 
Figure B: Number of research studies by country, proportion occurring in each 
World Health Organization region, & proportion occurring in countries by their 
World Bank Income Group 
Figure A: Meta-analysis workflow
METHODS CONTINUED
• While nearly four in five studies 
included women, less than one in five 
studies that form the basis for the 
current DRI for vitamins B12, B6, 
Folate, and Choline include pregnant 
and lactating people.  
• We found that for Vitamin B12 and 
Choline there is not a single study 
including pregnant or lactating 
people that informed the selection of 
indicators or for establishing the 
upper level (UL). 
• For Choline, there is not a single 
study including pregnant or lactating 
people that informed the selection of  
indicators, life stages, or for 
establishing the upper level (UL).   
• The highest %  of studies that included pregnant or lactating 
people were observed for folate, nearly double that of B12.
• No studies for selection of indicators or for establishing the 
upper level (UL) reported specific health outcomes for B12 or 
Choline.
• Less than 2% of the studies included in the DRIs for one-carbon metabolism 
micronutrients were conducted in Lower-Middle Income countries. No studies 
were conducted in Low-Income countries. 
RESULTS CONTINUED
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The current dietary reference intake values, which inform supplement formulations and nutrition policy in 
the US and globally, do not adequately include pregnant people for one-carbon metabolism micronutrients 
that are critical for a healthy pregnancy and birth outcomes. The DRIs demonstrate low geographic 
representativeness and may not be applicable to varying global population’s needs.
